 |
 Video: Compound Annual Growth Rate (CAGR) Definition
|
|
| Date |
Open |
High |
Low |
Close |
Volume |
| 12/14/2022 |
$0.14 |
$0.14 |
$0.10 |
$0.11 |
24.44M | | 12/15/2022 |
$0.11 |
$0.11 |
$0.09 |
$0.10 |
15.67M | | 12/16/2022 |
$0.10 |
$0.11 |
$0.08 |
$0.08 |
22.99M | | 12/19/2022 |
$0.08 |
$0.09 |
$0.08 |
$0.09 |
19.78M | | 12/20/2022 |
$0.08 |
$0.10 |
$0.08 |
$0.08 |
24.40M |
|
|
| Clovis Oncology is a biopharmaceutical company focused on acquiring, developing and commercializing anti-cancer agents. Co. markets Rubraca®, which is an oral small molecule inhibitor of poly ADP-ribose polymerase for indications specific to recurrent epithelial ovarian, fallopian tube or primary peritoneal cancer. Co.'s product candidates include: FAP-2286, a peptide-targeted radionuclide therapy and imaging agent targeting fibroblast activation protein; and Lucitanib, an oral potent angiogenesis inhibitor which inhibits vascular endothelial growth factor receptors 1 through 3, platelet-derived growth factor receptors alpha and beta and fibroblast growth factor receptors 1 through 3. | |
|
Clovis Oncology (CLVS) has the following price history information. Looking back at CLVS historical stock prices for the last five trading days, on December 14, 2022, CLVS opened at $0.14, traded as high as $0.14 and as low as $0.10, and closed at $0.11. Trading volume was a total of 24.44M shares. On December 15, 2022, CLVS opened at $0.11, traded as high as $0.11 and as low as $0.09, and closed at $0.10. Trading volume was a total of 15.67M shares. On December 16, 2022, CLVS opened at $0.10, traded as high as $0.11 and as low as $0.08, and closed at $0.08. Trading volume was a total of 22.99M shares. On December 19, 2022, CLVS opened at $0.08, traded as high as $0.09 and as low as $0.08, and closed at $0.09. Trading volume was a total of 19.78M shares. On December 20, 2022, CLVS opened at $0.08, traded as high as $0.10 and as low as $0.08, and closed at $0.08. Trading volume was a total of 24.40M shares.
CLVS Historical Stock Prices By Date:
Below, we examine the compound annual growth rate — CAGR for short — of an investment into Clovis Oncology shares, starting with a $10,000 purchase of CLVS, and working forward through the historical stock price information to today.
Growth of $10,000.00
Without Dividends Reinvested
|
| Start date: |
04/28/2014 |
|
| End date: |
12/20/2022 |
|
| Start price/share: |
$51.81 |
|
| End price/share: |
$0.08 |
|
| Dividends collected/share: |
$0.00 |
|
| Total return: |
-99.85% |
|
| Average Annual Total Return: |
-52.68% |
|
| Starting investment: |
$10,000.00 |
|
| Ending investment: |
$15.43 |
|
| Years: |
8.65 |
|
|
|
| Date |
Close |
| 12/14/2022 | $0.11 | | 12/15/2022 | $0.10 | | 12/16/2022 | $0.08 | | 12/19/2022 | $0.09 | | 12/20/2022 | $0.08 |
|
|
Free CLVS Email Alerts:
